Dr. Thomas Waldmann is chief of the NCI's Metabolism Branch. He earned his medical degree from Harvard and interned at Massachusetts General Hospital before joining NCI in 1956. He has devoted his career to NCI, and has headed the Metabolism Branch since 1971.
Dr. Waldmann's work in basic and clinical immunology focuses on the regulation of the human immune response and the disorders of this regulation in immunodeficiency diseases and malignancy.
Dr. Waldmann was the first to define and study suppressor T
cells in humans. He co-discovered a novel lymphokine, IL-15, that
stimulates T cell proliferation, and is critically involved in
the development and activation of natural killer cells.
Dr. Franklin Neva heads the Section on Opportunistic Parasitic
Diseases, in NIAID. Dr. Neva earned his medical degree at the
University of Minnesota Medical School. He spent a year as an
intern at Boston City Hospital and then two years on active duty
with a Naval medical research unit in Cairo. He returned to Boston
City Hospital for a year of residency in internal medicine and
completed a fellowship in microbiology at Harvard.
Dr. Neva held a number of positions at Harvard School of Public
Health and elsewhere before joining NIAID in 1969 as chief of
its Laboratory of Parasitic Diseases, where he has been ever since.
He has had a long and distinguished research career studying infectious
diseases such as leishmaniasis, Chagas' disease, malaria, and
strongyloidiasis.
 |
Questions about the Clinical Center or CC grand rounds? OCCC@nih.gov Or call: (301) 496-2563 National Institutes of Health, Warren Grant Magnuson Clinical Center, Bethesda, Maryland 20892. Last modified 5/99 |